Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPHEART.2001.280.2.H925PMID 11158995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contractile responses to human urotensin‐II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

  2000influential reference
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999influential reference
• Increased plasma levels of adrenomedullin in patients with pulmonary hypertension.

  1999cited by this paper
• Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction

  1999cited by this paper
• Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• Plasma levels of adrenomedullin in patients with acute myocardial infarction.

  1998cited by this paper
• Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat

  1998cited by this paper
• Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity

  1998cited by this paper
• Endothelin-1: an interesting peptide or an important mediator in pulmonary diseases?

  1998cited by this paper
• EndothelinB receptor‐mediated contraction in human pulmonary resistance arteries

  1996cited by this paper
• Complex effects of Gillichthys urotensin II on rat aortic strips

  1987cited by this paper

• Urotensin-II receptor contributes to the pro-inflammatory TLR4/MyD88/NF-κB/iNOS/NO pathway-mediated cardiovascular response to systemic lipopolysaccharide challenge in a septic shock model in rats.

  2025cites this paper
• Investigation of Urotensin II expression in placenta and umbilical cord in pregnancies with intrauterine growth restriction by histological and biochemical methods.

  2024cites this paper
• Urotensin II system in chronic kidney disease

  2024cites this paper
• Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes.

  2021cites this paper
• Urotensin receptor in GtoPdb v.2021.3

  2021cites this paper
• Urotensin II Induces Cardiac Fibrosis through the TGF-β/Smad Signaling Pathway during the Development of Cardiac Hypertrophy.

  2021cites this paper
• Effects of Resveratrol on the Level of Urotensin II and its Receptors in the Homogenized Tissue of Diabetic Rats

  2020cites this paper
• Urotensin receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Effects of Urotensin II on Excitation-Contraction Coupling in Hypertrophic Heart Failure

  2018cites this paper
• Long-scale molecular dynamics simulations of cyclic peptide hormones vasopressin, urotensin and analogues

  2017cites this paper
• Conformation and Dynamics of Human Urotensin II and Urotensin Related Peptide in Aqueous Solution

  2017cites this paper
• Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.

  2016cites this paper
• Oxidative Stress and Essential Hypertension

  2016cites this paper
• Renal Urotensin II System Plays Roles in the Regulation of Blood Pressure in Dahl Salt-Resistant Rat

  2016cites this paper
• Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

  2015cites this paper
• Related Peptide, and Their Receptor: From Structure to Function - International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II

  2015cites this paper
• Effect of Different Peptides

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015influential citation
• Oxidative stress in hypertension: mechanisms and therapeutic opportunities.

  2015cites this paper
• A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands

  2014cites this paper
• The Importence of Urotensin and Urotensin Receptors in Cardiovascular System

  2014cites this paper
• 2: Dyslipidemia and Atherosclerosis

  2014cites this paper
• Papel del estrés oxidativo en la patogénesis de la hipertensión arterial

  2014cites this paper
• Role of oxidative stress in the pathogenesis of hypertension

  2014cites this paper
• Molecular evolution of GPCRs: Somatostatin/urotensin II receptors.

  2014cites this paper
• Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.

  2014cites this paper
• New molecule in the etiology of schizophrenia: Urotensin II

  2014cites this paper
• Urotensin II (U-II), a novel cyclic peptide, possibly associated with the pathophysiology of osteoarthritis.

  2014cites this paper
• Essential hypertension and oxidative stress: New insights.

  2014cites this paper
• Pressor and renal regional hemodynamic effects of urotensin II in neonatal pigs

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure.

  2013cites this paper
• Association between Human Urotensin II and Essential Hypertension—A 1:1 Matched Case-Control Study

  2013cites this paper
• Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS

  2012cites this paper
• Vasoactive Molecules and the Kidney

  2012cites this paper
• Update on the urotensinergic system: new trends in receptor localization, activation, and drug design

  2012cites this paper
• A closer look at the role of urotensin II in the metabolic syndrome

  2012cites this paper
• Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?

  2012cites this paper
• Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.

  2011cites this paper
• Urotensin II Levels Are an Important Marker for the Severity of Portal Hypertension in Children

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• The role of oxidative stress in the pathophysiology of hypertension

  2011cites this paper
• Role of Novel Biomarkers in Chronic Kidney Disease: Urotensin II

  2010cites this paper
• Urotensin II: a novel target in human corpus cavernosum.

  2010cites this paper
• Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension.

  2010cites this paper
• Role of urotensin II in health and disease.

  2010cites this paper
• Expression of Urotensin II and Its Receptor in Human Liver Cirrhosis and Fulminant Hepatic Failure

  2010cites this paper
• Untersuchung der proteolytischen Prozessierung von humanen Urotensin-Peptiden

  2010influential citation
• Suche, Reinigung und Identifizierung eines Urotensin II metabolisierenden Enzyms

  2010cites this paper
• Urotensin II alters vascular reactivity in animals subjected to volume overload.

  2010cites this paper
• rotein expression of urotensin II , urotensin-related peptide and their eceptor in the lungs of patients with lymphangioleiomyomatosis

  2010cites this paper
• Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery.

  2010cites this paper
• The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans.

  2009cites this paper
• Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats.

  2009cites this paper
• Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

  2009cites this paper
• Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.

  2009cites this paper
• Urotensin II immunoreactivity in the human circulation: evidence for widespread tissue release.

  2009cites this paper
• The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems.

  2009cites this paper
• Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.

  2009cites this paper
• Relaxin : a new cardiovascular hormone in humans? : comparative potency and mechanisms of action

  2009cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas.

  2009cites this paper
• Skin vasodilator effect of exogenous urotensin‐II in hypertensives not exposed to antihypertensive medication

  2008cites this paper
• Biological properties and functional determinants of the urotensin II receptor.

  2008cites this paper
• XX EXPRESSION AND FUNCTIONAL ROLE OF UROTENSIN-II AND ITS RECEPTOR IN THE ADRENAL CORTEX AND MEDULLA

  2008cites this paper
• Urotensin II: A New Pharmacologic Target in the Treatment of Cardiovascular Disease

  2008cites this paper
• Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease

  2008cites this paper
• Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease.

  2008cites this paper
• Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.

  2008cites this paper
• The role of urotensin II in the metabolic syndrome.

  2008cites this paper
• Cardiorenovascular effects of urotensin II and the relevance of the UT receptor.

  2008cites this paper
• Urotensin-II Receptor

  2008cites this paper
• The Urotensin II System in Ischaemic Myocardial Dysfunction.

  2008cites this paper
• Urotensin II in cardiovascular regulation

  2008cites this paper
• Role of urotensin II in atherosclerotic cardiovascular diseases.

  2008cites this paper
• State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells.

  2008cites this paper
• Synthèse de ligands du récepteur de l'Urotensine II et des récepteurs de la Mélatonine : composés à noyau pyrido[2,3-d]pyrimidine ou imidazo[1,2-a]pyridine

  2008cites this paper
• Urotensin II and Cardiomyopathy in End-Stage Renal Disease

  2008cites this paper
• Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function.

  2008cites this paper
• Mutational Analysis of the Conserved Asp2.50 and ERY Motif Reveals Signaling Bias of the Urotensin II Receptor

  2008cites this paper
• Urotensin II: a cardiovascular and renal update

  2008cites this paper
• Hemodynamic-independent anti-natriuretic effect of urotensin II in spontaneously hypertensive rats.

  2008cites this paper
• Therapeutic potential of blockade of the Urotensin II system in systemic hypertension

  2007cites this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cites this paper
• Urotensin-II Immunoreactivity in Children with Chronic Glomerulonephritis

  2007cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• Urotensin II inhibits carotid sinus baroreflex in anesthetized male rats

  2007cites this paper
• Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.

  2007cites this paper
• Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling

  2007cites this paper
• Role of urotensin II and its receptor in health and disease

  2007cites this paper
• Chapter 32 – Other Peptide and Related Systems including Substance P, Calcitonin Gene-Related Peptide, and Serotonin

  2007cites this paper
• Vasoactive hormone studies in man using urotensin II and vasopressin

  2007cites this paper
• Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.

  2006cites this paper
• The etiology of hypertension in the metabolic syndrome part three: the regulation and dysregulation of blood pressure.

  2006cites this paper
• Urotensin II and ghrelin and target organ damage in primary hypertension

  2006cites this paper
• Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers.

  2006cites this paper
• Urotensin-II is a nitric oxide-dependent vasodilator in the pial arteries of the newborn pig.

  2006cites this paper
• Vascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide.

  2006cites this paper
• Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.

  2006cites this paper